Terveystalo Group Interim Report 1 January – 31 March, 2022: Strong growth continued in a shifting demand environment

Terveystalo Plc, Interim Report 28 April, 2022 at 09:00 EEST   This release is a summary of Terveystalo's Interim Report 1 January – 31 March, 2022. The full release is attached to this stock exchange release and is available on our website at: https://www.terveystalo.com/en/company/investors/reports-and-presentations/   January–March 2022 in brief · Revenue increased by 18.3% year-on-year to EUR 329.7 (278.7) million. The external revenue of the Sweden and others segment came to EUR 22.2 million representing 8.0 %-points of the revenue growth. · Adjusted[1)] earnings